Financial Performance - The company's operating revenue for Q3 2022 was ¥191,692,817.50, representing an increase of 18.22% compared to the same period last year[8]. - The net profit attributable to shareholders for Q3 2022 was ¥39,732,669.15, reflecting a growth of 4.26% year-over-year[8]. - The net profit after deducting non-recurring gains and losses was ¥37,927,870.79, which is an increase of 1.05% compared to the previous year[8]. - Year-to-date revenue reached ¥738,841,687.03, marking a significant increase of 61.60% compared to the same period last year[8]. - The basic earnings per share for Q3 2022 was ¥0.10, a decrease of 7.75% from the previous year[9]. - The weighted average return on equity was 1.89%, down by 0.60 percentage points compared to the previous year[9]. - The company reported a net profit margin improvement, with net profit for the first three quarters of 2022 reflecting a positive trend compared to the previous year[24]. - In Q3 2022, the company's net profit reached CNY 148,710,950.24, a 47% increase compared to CNY 101,072,534.57 in Q3 2021[25]. - The operating profit for Q3 2022 was CNY 198,774,133.63, up from CNY 136,652,358.47 in the same period last year, reflecting a growth of approximately 45.5%[25]. - The total comprehensive income for Q3 2022 was CNY 148,710,950.24, compared to CNY 101,072,534.57 in Q3 2021, indicating a growth of 47%[26]. - The basic and diluted earnings per share for Q3 2022 were both CNY 0.29, an increase from CNY 0.25 in Q3 2021[26]. Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached ¥738,841,687.03, a significant increase from ¥457,190,135.22 in the same period of 2021[24]. - Total operating costs for the first three quarters of 2022 were ¥541,449,154.31, compared to ¥320,162,486.27 in the first three quarters of 2021, indicating a rise in costs[24]. - The total revenue from sales of goods and services for the first three quarters of 2022 was CNY 459,656,414.89, compared to CNY 634,715,087.16 in the same period of 2021, reflecting a decline of about 27.5%[28]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,835,392,239.51, a decrease of 7.25% from the end of the previous year[9]. - Cash and cash equivalents as of September 30, 2022, amounted to ¥259,561,437.23, down from ¥397,249,611.88 at the end of 2021[20]. - Accounts receivable increased to ¥38,564,886.24 as of September 30, 2022, compared to ¥28,350,965.19 at the end of 2021, reflecting improved sales[20]. - Inventory decreased to ¥242,645,276.31 as of September 30, 2022, from ¥340,732,483.22 at the end of 2021, indicating better inventory management[20]. - Total assets as of September 30, 2022, were ¥2,835,392,239.51, down from ¥3,057,180,557.88 at the end of 2021[22]. - Total liabilities decreased to ¥629,637,523.64 as of September 30, 2022, from ¥898,926,713.85 at the end of 2021, showing improved financial health[22]. - Shareholders' equity increased to ¥2,205,754,715.87 as of September 30, 2022, compared to ¥2,158,253,844.03 at the end of 2021, indicating growth in company value[22]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥81,648,174.61, which decreased by 65.82% compared to the same period last year[9]. - Cash flow from operating activities for the first three quarters of 2022 was CNY 81,648,174.61, down from CNY 238,848,572.88 in the same period of 2021, a decrease of approximately 65.8%[28]. - The company reported a net cash outflow from investing activities of CNY -115,212,411.62 in the first three quarters of 2022, compared to CNY -53,214,424.66 in the same period of 2021[29]. - The cash and cash equivalents at the end of Q3 2022 were CNY 258,661,831.23, down from CNY 416,935,082.49 at the end of Q3 2021, a decrease of approximately 38%[29]. Research and Development - Research and development expenses increased significantly to CNY 5,194,810.25 in Q3 2022, compared to CNY 1,857,423.42 in Q3 2021, marking an increase of 179%[25]. Future Outlook - Future outlook includes potential market expansion and new product development strategies to enhance revenue growth[23]. - The company attributed the increase in revenue to the sales recognition from the Longyou Baiyi Agricultural Market[13]. - The company reported a total of 30,835 common shareholders at the end of the reporting period[15].
浙江东日(600113) - 2022 Q3 - 季度财报